Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Additional Insights
  3. Snapshot
  4. #7

Additional Insight · Snapshot · Review / Edit

Late-preterm antenatal corticosteroids – benefit versus hypoglycaemia

Record #7 · Edit the content, source and classification relationships.

PreviousNext
SQL status stored
Candidate visibility Not candidate-visible
Type Snapshot
Related questions 2
Additional Insights list

Additional Insight #7

Currently stored: stored

Status control does not offer the stored value. This record is stored as stored, but this legacy control only offers generated / needs_review / approved / retired. Saving will submit the selected value (currently generated) and replace stored.

This is a known backend issue reported separately; it has not been changed in this visual redesign.

Source

UUID — protected
fe51f4f4-7882-4fe0-8037-4f17c5d0dfcd
Cancel

Classification Relationships — through Subtopic3

1 assigned
Obstetrics and Gynaecology→ Clinical→ Feto-maternal medicine→ Maturity→ Related issue→ Steroid→ Adverse effect

Related Questions (2)

Matched through Subtopic3
SSBAQ51 generated
A woman at 36+0 weeks’ gestation is considered for antenatal corticosteroids because preterm birth is expected. During counselling she asks about an important short-term neonatal adverse effect demonstrated in late-preterm corticosteroid trials. Which adverse effect should be specifically discussed?
Feto-maternal medicine → Maturity → Related issue → Steroid → Adverse effect
Open Question
EEMQQ61 generated
Which of the following neonatal effects is particularly important after recent late-preterm antenatal corticosteroid exposure?
Feto-maternal medicine → Maturity → Related issue → Steroid → Adverse effect
Open Question